Results 161 to 170 of about 922,760 (302)
Digital patient experience tools in multiple sclerosis: a landscape analysis of the global Patient-Reported Outcomes in Multiple Sclerosis (PROMS) initiative. [PDF]
Tseriotis VS +11 more
europepmc +1 more source
Cognitive dysfunction and multiple sclerosis. [PDF]
Freedman DE, Feinstein A.
europepmc +1 more source
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper +7 more
wiley +1 more source
The association of multiple sclerosis with systemic inflammatory biomarkers: A case-control study exploring links with periodontal disease. [PDF]
Abed OK, Abbas RF.
europepmc +1 more source
Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: A multinational cohort study. [PDF]
Pierret C +8 more
europepmc +1 more source
Introduction Rheumatic and musculoskeletal diseases(RMDs) are leading causes of physical disability, necessitating support with activities of daily living(ADLs). This study describes social care received by patients with RMDs in two disperate regions of England: Salford(urban) and Norfolk(rural).
Mehreen Somro +6 more
wiley +1 more source
Paroxysmal motor signs in multiple sclerosis: an illustrative videotaped case. [PDF]
Lahmam G +7 more
europepmc +1 more source
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli +10 more
wiley +1 more source

